The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial
灭活 SARS-CoV-2 疫苗在中国 18-59 岁成年人中的安全性和免疫原性:一项 I 期随机、双盲、对照试验
期刊:Vaccine
影响因子:4.5
doi:10.1016/j.vaccine.2021.04.006
Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Qiongzhou Yin, Hongbo Chen, Runxiang Long, Zhimei Zhao, Tangwei Mou, Heng Zhao, Shiyin Feng, Zhongping Xie, Lichun Wang, Zhanlong He, Yun Liao, Shengtao Fan, Ruiju Jiang, Jianfeng Wang, Lingli Zhang, Jing Li, Huiwen Zheng, Pingfang Cui, Guorun Jian